scholarly article | Q13442814 |
P356 | DOI | 10.1136/JNNP-2015-311952 |
P698 | PubMed publication ID | 26746186 |
P50 | author | Albert C. Ludolph | Q67390363 |
Julian Grosskreutz | Q77487572 | ||
Martin R. Turner | Q39982364 | ||
Massimo Filippi | Q48131182 | ||
Jan Kassubek | Q56956567 | ||
P2093 | author name string | Hans-Peter Müller | |
Peter Bede | |||
Sharon Abrahams | |||
Johannes Prudlo | |||
Varan Govind | |||
Neuroimaging Society in ALS (NiSALS) DTI Study Group | |||
P2860 | cites work | Lessons of ALS imaging: Pitfalls and future directions - A critical review | Q26860864 |
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases | Q26996441 | ||
Thresholding of statistical maps in functional neuroimaging using the false discovery rate | Q28208414 | ||
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data | Q28683731 | ||
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
Diffusion tensor imaging: concepts and applications | Q30643031 | ||
25 years of neuroimaging in amyotrophic lateral sclerosis. | Q30659482 | ||
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis | Q30660585 | ||
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach | Q30687540 | ||
Preferential detachment during human brain development: age- and sex-specific structural connectivity in diffusion tensor imaging (DTI) data | Q30716889 | ||
Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease | Q30846955 | ||
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes | Q30873214 | ||
Biomarkers in amyotrophic lateral sclerosis | Q33392844 | ||
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis | Q34044019 | ||
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease | Q34151259 | ||
A framework for the analysis of phantom data in multicenter diffusion tensor imaging studies | Q34213592 | ||
Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis | Q34281282 | ||
Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis | Q34470152 | ||
Inter subject variability and reproducibility of diffusion tensor imaging within and between different imaging sessions. | Q34804806 | ||
Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0T scanners | Q35186650 | ||
The central nervous system in motor neurone disease | Q37069867 | ||
NERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS | Q37153315 | ||
Stages of pTDP-43 pathology in amyotrophic lateral sclerosis | Q37202139 | ||
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging | Q37220884 | ||
The present and the future of neuroimaging in amyotrophic lateral sclerosis | Q37723166 | ||
Amyotrophic lateral sclerosis--a model of corticofugal axonal spread | Q38161789 | ||
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis | Q38257430 | ||
Neuroimaging of motor neuron diseases | Q39638383 | ||
Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. | Q39642060 | ||
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner | Q41779442 | ||
Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study | Q42046993 | ||
Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study | Q42647714 | ||
Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology | Q44404880 | ||
A brighter future for patients with amyotrophic lateral sclerosis through imaging? | Q44459334 | ||
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects | Q44459495 | ||
Multicenter stability of diffusion tensor imaging measures: a European clinical and physical phantom study | Q45348464 | ||
A revision of the El Escorial criteria - 2015. | Q46384721 | ||
The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract | Q46644614 | ||
Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis | Q46898128 | ||
Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers | Q47283656 | ||
Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. | Q48235526 | ||
A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy and diffusivity values. | Q48773710 | ||
Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study | Q48827615 | ||
Age-related alterations in white matter microstructure measured by diffusion tensor imaging | Q48884470 | ||
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). | Q53535985 | ||
Neuroimaging in amyotrophic lateral sclerosis | Q57498892 | ||
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis | Q57498933 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multicenter clinical trial | Q6934595 |
amyotrophic lateral sclerosis | Q206901 | ||
diffusion tensor imaging | Q30088257 | ||
P304 | page(s) | 570-579 | |
P577 | publication date | 2016-01-08 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis | |
P478 | volume | 87 |
Q90351947 | Abnormal topological organization of structural covariance networks in amyotrophic lateral sclerosis |
Q57142256 | Amyotrophic lateral sclerosis: the complex path to precision medicine |
Q38659598 | Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials. |
Q26747024 | Assessment of the upper motor neuron in amyotrophic lateral sclerosis |
Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
Q57817271 | Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis |
Q48515476 | Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study |
Q52674609 | Current Clinical Applications of Diffusion-Tensor Imaging in Neurological Disorders. |
Q30365956 | Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. |
Q60046947 | Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a "Global Cohort" |
Q36209956 | Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study |
Q100995465 | Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model |
Q55127801 | Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. |
Q92537437 | Editorial: Biomarkers and Clinical Indicators in Motor Neuron Disease |
Q48869495 | Emergence of an imaging biomarker for amyotrophic lateral sclerosis: is the end point near? |
Q60046948 | Emerging Magnetic Resonance Imaging Techniques and Analysis Methods in Amyotrophic Lateral Sclerosis |
Q39041271 | Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. |
Q42654900 | Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis |
Q89957102 | Focal alterations of the callosal area III in primary lateral sclerosis: An MRI planimetry and texture analysis |
Q89847262 | Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): a longitudinal MRI one-year study |
Q39120765 | Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis |
Q54989554 | Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study. |
Q60916442 | Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis |
Q47661027 | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
Q50072712 | Investigating the neuroanatomical substrate of pathological laughing and crying in amyotrophic lateral sclerosis with multimodal neuroimaging techniques |
Q51761125 | Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD). |
Q47151321 | Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis |
Q37497445 | Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype |
Q57491530 | MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis |
Q64087673 | Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions |
Q60049281 | Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease |
Q54379389 | Microglial activation, white matter tract damage, and disability in MS. |
Q90639143 | Mirror Movements in Amyotrophic Lateral Sclerosis: A Combined Study Using Diffusion Tensor Imaging and Transcranial Magnetic Stimulation |
Q92078215 | Multicomponent diffusion analysis reveals microstructural alterations in spinal cord of a mouse model of amyotrophic lateral sclerosis ex vivo |
Q47404494 | Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: evidence from MRI and MEG studies. |
Q38983572 | Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis |
Q61814992 | Neuroimaging in Hereditary Spastic Paraplegias: Current Use and Future Perspectives |
Q37553471 | Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis |
Q89282366 | Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis |
Q52092218 | Revealing the microstructural brain damage in amyotrophic lateral sclerosis: the relentless pursuit to approach an imaging biomarker. |
Q64119028 | Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques |
Q58711830 | Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9 |
Q64943856 | Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study. |
Q91572614 | Texture Analysis to Detect Cerebral Degeneration in Amyotrophic Lateral Sclerosis |
Q92673455 | The same cortico-efferent tract involvement in progressive bulbar palsy and in 'classical' ALS: A tract of interest-based MRI study |
Q28067928 | The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review |
Q64075393 | Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS |
Q64109562 | Tract integrity in amyotrophic lateral sclerosis: 6-month evaluation using MR diffusion tensor imaging |
Q58126531 | UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis |
Q91595179 | Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis |
Q33822826 | Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns |
Q64062458 | White Matter Microstructure Breakdown in the Motor Neuron Disease Spectrum: Recent Advances Using Diffusion Magnetic Resonance Imaging |
Search more.